Australia markets close in 3 hours 19 minutes

Zealand Pharma A/S (ZEAL)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
31.96+0.14 (+0.45%)
At close: 3:55PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

Currency in DKK. All numbers in thousands
Breakdown
ttm
31/12/2020
31/12/2019
31/12/2018
31/12/2017
Total revenue
252,027
353,314
41,333
37,977
139,775
Cost of revenue
128,841
90,565
415
180,238
14,629
Gross profit
123,186
262,749
40,918
-142,261
125,146
Operating expenses
Research development
597,391
604,081
561,423
438,215
324,667
Selling general and administrative
674,139
488,026
67,881
78,001
47,470
Total operating expenses
1,271,851
1,091,505
628,860
515,586
371,530
Operating income or loss
-1,148,665
-828,756
-587,942
-657,847
-246,384
Interest expense
3,202
2,895
3,205
15,080
18,913
Total other income/expenses net
10,670
-4,068
9,242
1,313,692
-7,825
Income before tax
-1,145,109
-839,653
-576,677
625,056
-277,771
Income tax expense
3,011
7,076
-5,136
43,774
-5,500
Income from continuing operations
-1,148,120
-846,729
-571,541
581,282
-272,271
Net income
-1,148,120
-846,729
-571,541
581,282
-272,271
Net income available to common shareholders
-1,148,120
-846,729
-571,541
581,282
-272,271
Basic EPS
-
-22.07
-16.91
18.94
-9.77
Diluted EPS
-
-22.07
-16.91
18.94
-9.77
Basic average shares
-
38,370
33,802
30,691
27,854
Diluted average shares
-
38,370
33,802
30,696
27,854
EBITDA
-
-794,066
-559,790
644,644
-254,101